Bone markers in the management of patien
β
Laurence M. Demers
π
Article
π
2003
π
John Wiley and Sons
π
English
β 132 KB
π 1 views
## Background: Biochemical markers of bone remodeling have been used as surrogate markers to manage patients with metastatic bone disease. markers of the bone resorptive process, such as the bone collagen breakdown products n-telopeptide and c-telopeptide, are useful markers for monitoring the resp